Currently out of the existing stock ratings of Sam Eiber, 28 are a BUY (100%).

Sam Eiber

Work Performance Price Targets & Ratings Chart

Analyst Sam Eiber, currently employed at BTIG, carries an average stock price target met ratio of 21.3% that have a potential upside of 8% achieved within 28 days.

Sam Eiber’s has documented 56 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on STIM, Neuronetics at 17-Sep-2026.

Wall Street Analyst Sam Eiber

Analyst best performing recommendations are on ESTA (ESTABLISHMENT LABS HOLDINGS).
The best stock recommendation documented was for ESTA (ESTABLISHMENT LABS HOLDINGS) at 4/29/2026. The price target of $88 was fulfilled within 57 days with a profit of $25.57 (40.96%) receiving and performance score of 7.19.

Average potential price target upside

BWAY Brainsway Ltd EOLS Evolus ESTA Establishment Labs Holdings ICUI ICU Medical MMSI Merit Medical Systems STIM Neuronetics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Jul-2021

$19

$7.75 (68.89%)

$19

7 days ago
(19-Oct-2026)

16/23 (69.57%)

$7.01 (58.47%)

301

Buy Since 20-Jul-2026

$20

$8.75 (77.78%)

$20

1 months 16 days ago
(10-Sep-2026)

0/3 (0%)

$6.09 (43.78%)

Buy Since 13-May-2019

$18.8

$7.55 (67.11%)

$8.5

2 months 13 days ago
(13-Aug-2026)

2/3 (66.67%)

$2.33 (14.15%)

1928

Buy Since 10-Feb-2022

$11.5

$-2.98 (-20.58%)

$9.5

11 months 14 days ago
(12-Nov-2025)

4/4 (100%)

$3.61 (45.75%)

115

Buy Since 13-May-2019

$7.5

$-6.98 (-48.20%)

$2.75

1 years 5 months 12 days ago
(14-May-2025)

4/4 (100%)

$2.36 (45.91%)

100

Show more analysts

Please expand the browser size to see the chart

Which stock is Sam Eiber most bullish on?

Potential upside of $39.2 has been obtained for ESTA (ESTABLISHMENT LABS HOLDINGS)

Which stock is Sam Eiber most reserved on?

Potential downside of $3.89 has been obtained for STIM (NEURONETICS)

What Year was the first public recommendation made by Sam Eiber?

On 2025
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?